Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRK5 intronic transcript 1 (GRK5-IT1) refers to an intronic region within the G protein-coupled receptor kinase 5 (GRK5) gene, notably encompassing the single nucleotide polymorphism rs10886471 and associated short tandem repeat (CA)n elements. These intronic variants have been linked to altered GRK5 mRNA expression by modulating splicing enhancers or repressors, influencing metabolic disease risk such as type 2 diabetes mellitus. However, this designation does not correspond to a well-defined or targetable protein or receptor, and its scientific usage is limited to regulatory genetics studies rather than pharmacology or therapeutic development[1][3].
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRK5 intronic transcript 1 (GRK5-IT1).